ARTICLE | Company News
Response Biomedical, Roche deal
August 1, 2005 7:00 AM UTC
ROCZ's Roche Diagnostics unit granted RBM a non-exclusive license to patents rights covering N-terminal prohormone brain natriuretic peptide, a cardiovascular marker, for use in developing diagnostics...